BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35379653)

  • 1. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
    Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
    BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets.
    Huang C; Xing X; Xiang X; Fan X; Men R; Ye T; Yang L
    Biomed Pharmacother; 2020 Oct; 130():110558. PubMed ID: 32781357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
    Migita K; Komori A; Kozuru H; Jiuchi Y; Nakamura M; Yasunami M; Furukawa H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Kamitsukasa H; Nakamura Y; Ohta H; Shimada M; Takahashi H; Mita E; Hijioka T; Yamashita H; Kouno H; Nakamuta M; Ario K; Muro T; Sakai H; Sugi K; Nishimura H; Yoshizawa K; Sato T; Naganuma A; Komatsu T; Oohara Y; Makita F; Tomizawa M; Yatsuhashi H
    PLoS One; 2015; 10(11):e0136908. PubMed ID: 26575387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.
    Kobayashi M; Kakuda Y; Harada K; Sato Y; Sasaki M; Ikeda H; Terada M; Mukai M; Kaneko S; Nakanuma Y
    World J Gastroenterol; 2014 Apr; 20(13):3597-608. PubMed ID: 24707143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis.
    Lian JS; Liu W; Hao SR; Chen DY; Wang YY; Yang JL; Jia HY; Huang JR
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):413-21. PubMed ID: 26256087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis.
    Szekerczés T; Gógl A; Illyés I; Mandl J; Borka K; Kiss A; Schaff Z; Lendvai G; Werling K
    Pathol Oncol Res; 2020 Oct; 26(4):2143-2151. PubMed ID: 32124227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
    Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
    World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
    Park Y; Cho Y; Cho EJ; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.
    Schultheiß C; Steinmann S; Willscher E; Paschold L; Lohse AW; Binder M
    Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
    Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating extracellular vesicle-encapsulated microRNA-557 induces a proinflammatory immune response and serves as a diagnostic or relapse marker in autoimmune hepatitis.
    Abe K; Suzuki R; Fujita M; Hayashi M; Takahashi A; Ohira H
    Hepatol Res; 2022 Dec; 52(12):1034-1049. PubMed ID: 35962993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
    Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
    Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis.
    Yao M; Wang L; Wang J; Liu Y; Liu S; Zhao J; Lu F
    Dis Markers; 2022; 2022():4253566. PubMed ID: 35075376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophage migration inhibitory factor in autoimmune liver disease.
    Assis DN; Leng L; Du X; Zhang CK; Grieb G; Merk M; Garcia AB; McCrann C; Chapiro J; Meinhardt A; Mizue Y; Nikolic-Paterson DJ; Bernhagen J; Kaplan MM; Zhao H; Boyer JL; Bucala R
    Hepatology; 2014 Feb; 59(2):580-91. PubMed ID: 23913513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome.
    Li Z; Liu Y; Yang F; Pang J; Wu Y; Chong Y; Li X
    Biomed Res Int; 2020; 2020():1934541. PubMed ID: 32626734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
    Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
    Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.